Chronic cough clinical trials

Explore recruiting chronic cough clinical trials.

Recruiting chronic cough studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic cough trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Taplucainium Inhalation Powder (NOC-110) in Adults with Refractory or Unexplained Chronic Cough

Belgium, Poland, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study with Open-Label Extension of BLU-5937 in Adult Participants with Refractory Chronic Cough, Including Unexplained Chronic Cough (CALM-1)

Netherlands, Poland, Belgium, Spain, Hungary, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of the effect of CHF6795 on the pharmacokinetics of midazolam, repaglinide and rosuvastatin in healthy subjects

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 3, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study with Open-label Extension of BLU-5937 in Adult Participants with Refractory Chronic Cough Including Unexplained Chronic Cough (CALM-2)

Germany, Slovakia, Czechia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic cough trials by city

Chronic cough in Toronto Chronic cough in Vancouver Chronic cough in Montreal Chronic cough in Calgary Chronic cough in Edmonton Chronic cough in Ottawa Chronic cough in Winnipeg Chronic cough in Quebec City Chronic cough in Hamilton Chronic cough in Kitchener Chronic cough in London Chronic cough in Halifax Chronic cough in New York Chronic cough in Los Angeles Chronic cough in Chicago Chronic cough in Houston

Other conditions

OCD ADHD Insomnia Postpartum depression Alcohol use disorder Substance use disorder COPD Asthma Long COVID Cystic fibrosis Pulmonary fibrosis Sleep apnea Crohn's disease Ulcerative colitis Irritable bowel syndrome Celiac disease GERD Eosinophilic esophagitis Gastroparesis Rheumatoid arthritis Lupus Psoriatic arthritis Ankylosing spondylitis Osteoarthritis